Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease

Atherosclerosis

Volumn 227, Issue 1, 2013, Pages 130-134

  Ishii, Hideki ^a   Aoyama, Toru ^b   Takahashi, Hiroshi ^b   Kamoi, Daisuke ^b   Tanaka, Miho ^a   Yoshikawa, Daiji ^a   Hayashi, Mutsuharu ^a   Matsubara, Tatsuaki ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Endovascular; Follow up studies; Hemodialysis; Stent; Target vessel revascularization

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AMPUTATION; ARTICLE; BLOOD ANALYSIS; DEATH; EVENT FREE SURVIVAL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS THROMBECTOMY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; REVASCULARIZATION; SEX DIFFERENCE; TREATMENT OUTCOME;

AGED; AMPUTATION; ANGIOPLASTY, BALLOON; C-REACTIVE PROTEIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SERUM ALBUMIN;

EID: 84873427235     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.11.034     Document Type: Article

References (24)

1. United States renal data system. Annual data report. Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease, Division of Kidney, Urologic and Hematologic Disease; 2000. p. 339-48.
2. Graziani L., Silvestro A., Bertone V., et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant 2007, 22:1144-1149.
3. Kumada Y., Aoyama T., Ishii H., et al. Long-term outcome of percutaneous transluminal angioplasty in chronic haemodialysis patients with peripheral arterial disease. Nephrol Dial Transplant 2008, 23:3996-4001.
4. O'Hare A.M., Sidawy A.N., Feinglass J., et al. Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg 2004, 39:709-716.
5. Korn P., Hoenig S.J., Skillman J.J., Kent K.C. Is lower extremity revascularization worthwhile in patients with end-stage renal disease?. Surgery 2000, 128:472-479.
6. Arici M., Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?. Kidney Int 2001, 59:407-414.
7. Yeun J.Y., Levine R.A., Mantadilok V., Kaysen G.A. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000, 35:469-476.
8. Ishii H., Toriyama T., Aoyama T., et al. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Circ Cardiovasc Intervent 2009, 2:513-518.
9. Ishii H., Kumada Y., Toriyama T., Aoyama T., Takahashi H., Murohara T. Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease. J Vasc Surg 2010, 52:854-859.
10. Stenvinkel P., Heimbürger O., Lindholm B., Kaysen G.A., Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000, 15:953-960.
11. Stenvinkel P., Heimbürger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999, 55:1899-1911.
12. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., TASC II Working Group Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007, 45(Suppl. S):S5-S67.
13. O'Hare A.M., Hsu C.Y., Bacchetti P., Johansen K.L. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol 2002, 13:497-503.
14. Herzog C.A., Asinger R.W., Berger A.K., et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011, 80:572-586.
15. O'Hare A.M. Management of peripheral arterial disease in chronic kidney disease. Cardiol Clin 2005, 23:225-236.
16. Jaar B.G., Astor B.C., Berns J.S., Powe N.R. Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. Kidney Int 2004, 65:613-620.
17. Goldstein J.A., Chandra H.R., O'Neill W.W. Relation of number of complex coronary lesions to serum C-reactive protein levels and major adverse cardiovascular events at one year. Am J Cardiol 2005, 96:56-60.
18. Thakore A.H., Guo C.Y., Larson M.G., et al. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007, 99:1598-1602.
19. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
20. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
21. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
22. Pepys M.B., Hirschfield G.M., Tennent G.A., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006, 440:1217-1221.
23. Rambod M., Bross R., Zitterkoph J., et al. Association of malnutrition-inflammation score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis 2009, 53:298-309.
24. Ishii H., Kumada Y., Toriyama T., et al. Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease. Clin J Am Soc Nephrol 2008, 3:1034-1040.